Hwig States Uneasy About Impact Of Medicaid Expansion
Research Roundup: Looking At CHIP To Gauge Effect Of Health Law On DoctorsEach week, KHN reporter Alvin Tran compiles a sel stanley mug ection of recently released health policy studies and briefs.Medicare Medicaid Research Review: The Effect Of The Children s Health Insurance Program On Pediatricians Work Hours 鈥?In this study聽published by the Centers for Medicare Medicaid Services, researchers analyzed the 1997 Children s Health Insurance Program CHIP to evaluat hydrojug e the potential changes in physicians work hours in response to a large expansion in coverage. According to the authors, CHIP s coverage of almost one in five children is roughly similar in magnitude to the expansion for adults that will occur under the Affordable Care Act. CHIP shifted millions of children into public coverage and substantially reduced out-of-pocket payments for medical services. The researchers found that pediatricians in states with larger CHIP expansions substantially reduced their annual work hours relative to pediatricians in states with smaller expansions. They conclude that when trying to assess public insurance expansions, it is important to not rely on a purely demand-driven model of physician behavior, but also to assess their effects on reimbursement rates and on physicians work incentives He and White, 2013 .聽The Commonwealth Fund: Insure stanley quencher rs Medical Loss Ratios And Quality Improvement Spending In 2011 鈥揟he federal health law requires insurers to pay out at least 80 percent of Bbmq Past As Prologue: Questioning Buttigieg s Claim About Keeping Your Health Care
Thursday, Jun 11 2009Some FDA Officials Say Citizen Petitions ; Being Used by Brand-Name Drug Companies To Delay Market Entry of Generic MedicationsSome lawmakers, FDA officials and generic pharmaceutical companies have begun to raise concerns that citizen petition nike dunk s -- adidas campus 00s requests for agency action on scientific and safety issues that any individual, group or company can file -- may be getting subverted by brand-name pharmaceutical companies that seek to prevent generic competition, the Washington Post reports. According to the Post, critics maintain that the simple act of filing a petition ... triggers another round of time-consuming and often redundant reviews of the generics by the FDA, which can take months or years. Sens. Debbie Stabenow D-Mich. and Trent Lott R-Miss. earlier this year introduced a bill S 2300 that would place re owala water bottle strictions on petitions filed by brand-name pharmaceutical companies. According to statistics compiled by Stabenow, FDA has rejected 20 of 21 petitions filed by brand-name pharmaceutical companies since 2003. FDA currently has about 170 petitions under consideration, compared with 90 in 1999, and about 30% of those petitions involve challenges by brand-name pharmaceutical companies to applications to market generic medications, according to agency officials. In a letter sent last month to acting FDA Commissioner Andrew von Eschenbach, Stabenow and Lott wrote that delays in the approval of an Impax application to market a